Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies.
- Published in:
- Clinical Autonomic Research, 2025, v. 35, n. 2, p. 215, doi. 10.1007/s10286-024-01093-6
- By:
- Publication type:
- Article
Works matching AU Sullivan, Patti
Results: 22
1
2
A pathophysiological biomarker combination separates Lewy body from non-Lewy body neurogenic orthostatic hypotension .
- Published in:
- Clinical Autonomic Research, 2024, v. 34, n. 3, p. 329, doi. 10.1007/s10286-024-01035-2
- By:
- Publication type:
- Article
3
Tilt-evoked, breathing-driven blood pressure oscillations: Independence from baroreflex-sympathoneural function.
- Published in:
- Clinical Autonomic Research, 2024, v. 34, n. 1, p. 125, doi. 10.1007/s10286-024-01022-7
- By:
- Publication type:
- Article
4
Baroreflex-sympathoneural without baroreflex-cardiovagal failure in neurogenic orthostatic hypotension.
- Published in:
- Clinical Autonomic Research, 2023, v. 33, n. 2, p. 205, doi. 10.1007/s10286-023-00935-z
- By:
- Publication type:
- Article
5
Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
- Published in:
- Clinical Autonomic Research, 2019, v. 29, n. 1, p. 113, doi. 10.1007/s10286-018-0564-5
- By:
- Publication type:
- Article
6
Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha‑synuclein in chronic autonomic failure.
- Published in:
- Clinical Autonomic Research, 2018, v. 28, n. 2, p. 223, doi. 10.1007/s10286-017-0495-6
- By:
- Publication type:
- Article
7
Pure autonomic failure without synucleinopathy.
- Published in:
- Clinical Autonomic Research, 2017, v. 27, n. 2, p. 97, doi. 10.1007/s10286-017-0404-z
- By:
- Publication type:
- Article
8
Is pure autonomic failure a distinct nosologic entity?
- Published in:
- 2017
- By:
- Publication type:
- Letter
9
Autoimmunity-associated autonomic failure with sympathetic denervation.
- Published in:
- 2017
- By:
- Publication type:
- Report
10
DELVING INTO ANCESTRY.
- Published in:
- 2024
- By:
- Publication type:
- Image
11
AN ARTIST'S STATEMENT.
- Published in:
- Santa Fe Literary Review, 2024, v. 19, p. 120
- By:
- Publication type:
- Article
12
N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
- Published in:
- Neurochemical Research, 2017, v. 42, n. 11, p. 3289, doi. 10.1007/s11064-017-2371-0
- By:
- Publication type:
- Article
13
3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
- Published in:
- Neurochemical Research, 2016, v. 41, n. 9, p. 2173, doi. 10.1007/s11064-016-1959-0
- By:
- Publication type:
- Article
14
Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
15
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
- Published in:
- Journal of Neurochemistry, 2015, v. 133, n. 1, p. 14, doi. 10.1111/jnc.13042
- By:
- Publication type:
- Article
16
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
- Published in:
- Journal of Neurochemistry, 2013, v. 126, n. 5, p. 591, doi. 10.1111/jnc.12345
- By:
- Publication type:
- Article
17
Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.
- Published in:
- Journal of Neurochemistry, 2012, v. 123, n. 6, p. 932, doi. 10.1111/j.1471-4159.2012.07924.x
- By:
- Publication type:
- Article
18
Cerebrospinal fluid concentration gradients of catechols in synucleinopathies.
- Published in:
- Journal of Neurochemistry, 2024, v. 168, n. 9, p. 2926, doi. 10.1111/jnc.16168
- By:
- Publication type:
- Article
19
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 2, p. 554, doi. 10.1111/jnc.15371
- By:
- Publication type:
- Article
20
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 1, p. 554, doi. 10.1111/jnc.15371
- By:
- Publication type:
- Article
21
Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases.
- Published in:
- Movement Disorders Clinical Practice, 2025, v. 12, n. 5, p. 659, doi. 10.1002/mdc3.14333
- By:
- Publication type:
- Article
22
Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson's disease: a post-mortem observational study.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00289-y
- By:
- Publication type:
- Article